{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:12:08Z","timestamp":1761765128561,"version":"3.37.3"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1124\/jpet.109.150896","type":"journal-article","created":{"date-parts":[[2009,3,24]],"date-time":"2009-03-24T01:41:10Z","timestamp":1237858870000},"page":"900-907","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Erythropoietin Protects the Heart from Ventricular Arrhythmia during Ischemia and Reperfusion via Neuronal Nitric-Oxide Synthase"],"prefix":"10.1016","volume":"329","author":[{"given":"Dylan E.","family":"Burger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu-Li","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lamis","family":"Hammoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas L.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingping","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.109.150896_bib1","unstructured":"Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, et al. (2004) ACC\/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of patients with acute myocardial infarction). J Am Coll Cardiol 44: E1-E211."},{"key":"10.1124\/jpet.109.150896_bib2","doi-asserted-by":"crossref","unstructured":"Asaumi Y, Kagaya Y, Takeda M, Yamaguchi N, Tada H, Ito K, Ohta J, Shiroto T, Shirato K, Minegishi N, et al. (2007) Protective role of endogenous erythropoietin system in nonhematopoietic cells against pressure overload-induced left ventricular dysfunction in mice. Circulation 115: 2022-2032.","DOI":"10.1161\/CIRCULATIONAHA.106.659037"},{"key":"10.1124\/jpet.109.150896_bib3","doi-asserted-by":"crossref","unstructured":"Belonje AM, Voors AA, van Gilst WH, Anker SD, Slart RH, Tio RA, Zijlstra F, and van Veldhuisen DJ (2008) Effects of erythropoietin after an acute myocardial infarction: rationale and study design of a prospective, randomized, clinical trial (HEBE III). Am Heart J 155: 817-822.","DOI":"10.1016\/j.ahj.2007.12.036"},{"key":"10.1124\/jpet.109.150896_bib4","doi-asserted-by":"crossref","unstructured":"Bernaudin M, Marti HH, Roussel S, Divoux D, Nouvelot A, MacKenzie ET, and Petit E (1999) A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J Cereb Blood Flow Metab 19: 643-651.","DOI":"10.1097\/00004647-199906000-00007"},{"key":"10.1124\/jpet.109.150896_bib5","doi-asserted-by":"crossref","unstructured":"Burger D, Lei M, Geoghegan-Morphet N, Lu X, Xenocostas A, and Feng Q (2006) Erythropoietin protects cardiomyocytes from apoptosis via up-regulation of endothelial nitric oxide synthase. Cardiovasc Res 72: 51-59.","DOI":"10.1016\/j.cardiores.2006.06.026"},{"key":"10.1124\/jpet.109.150896_bib6","doi-asserted-by":"crossref","unstructured":"Burger D, Xenocostas A, and Feng Q (2009) Molecular basis of cardioprotection by erythropoietin. Curr Mol Pharmacol 2: 56-69.","DOI":"10.2174\/1874-470210902010056"},{"key":"10.1124\/jpet.109.150896_bib7","doi-asserted-by":"crossref","unstructured":"Burkard N, Rokita AG, Kaufmann SG, Hallhuber M, Wu R, Hu K, Hofmann U, Bonz A, Frantz S, Cartwright EJ, et al. (2007) Conditional neuronal nitric oxide synthase overexpression impairs myocardial contractility. Circ Res 100: e32-e44.","DOI":"10.1161\/01.RES.0000259042.04576.6a"},{"key":"10.1124\/jpet.109.150896_bib8","doi-asserted-by":"crossref","unstructured":"Calvillo L, Latini R, Kajstura J, Leri A, Anversa P, Ghezzi P, Salio M, Cerami A, and Brines M (2003) Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling. Proc Natl Acad Sci U S A 100: 4802-4806.","DOI":"10.1073\/pnas.0630444100"},{"key":"10.1124\/jpet.109.150896_bib9","doi-asserted-by":"crossref","unstructured":"Campbell RW, Murray A, and Julian DG (1981) Ventricular arrhythmias in first 12 hours of acute myocardial infarction: natural history study. Br Heart J 46: 351-357.","DOI":"10.1136\/hrt.46.4.351"},{"key":"10.1124\/jpet.109.150896_bib10","doi-asserted-by":"crossref","unstructured":"Fisher JW (2003) Erythropoietin: physiology and pharmacology update. Exp Biol Med (Maywood) 228: 1-14.","DOI":"10.1177\/153537020322800101"},{"key":"10.1124\/jpet.109.150896_bib11","doi-asserted-by":"crossref","unstructured":"Gonzalez DR, Beigi F, Treuer AV, and Hare JM (2007) Deficient ryanodine receptor S-nitrosylation increases sarcoplasmic reticulum calcium leak and arrhythmogenesis in cardiomyocytes. Proc Natl Acad Sci U S A 104: 20612-20617.","DOI":"10.1073\/pnas.0706796104"},{"key":"10.1124\/jpet.109.150896_bib12","doi-asserted-by":"crossref","unstructured":"Hamed S, Barshack I, Luboshits G, Wexler D, Deutsch V, Keren G, and George J (2006) Erythropoietin improves myocardial performance in doxorubicin-induced cardiomyopathy. Eur Heart J 27: 1876-1883.","DOI":"10.1093\/eurheartj\/ehl044"},{"key":"10.1124\/jpet.109.150896_bib13","doi-asserted-by":"crossref","unstructured":"Hammoud L, Xiang F, Lu X, Brunner F, Leco K, and Feng Q (2007) Endothelial nitric oxide synthase promotes neonatal cardiomyocyte proliferation by inhibiting tissue inhibitor of metalloproteinase-3 expression. Cardiovasc Res 75: 359-368.","DOI":"10.1016\/j.cardiores.2007.05.006"},{"key":"10.1124\/jpet.109.150896_bib14","doi-asserted-by":"crossref","unstructured":"Han G, Ma H, Chintala R, Miyake K, Fulton DJ, Barman SA, and White RE (2007) Nongenomic, endothelium-independent effects of estrogen on human coronary smooth muscle are mediated by type I (neuronal) NOS and PI3-kinase-Akt signaling. Am J Physiol Heart Circ Physiol 293: H314-H321.","DOI":"10.1152\/ajpheart.01342.2006"},{"key":"10.1124\/jpet.109.150896_bib15","doi-asserted-by":"crossref","unstructured":"Hanlon PR, Fu P, Wright GL, Steenbergen C, Arcasoy MO, and Murphy E (2005) Mechanisms of erythropoietin-mediated cardioprotection during ischemia-reperfusion injury: role of protein kinase C and phosphatidylinositol 3-kinase signaling. FASEB J 19: 1323-1325.","DOI":"10.1096\/fj.04-3545fje"},{"key":"10.1124\/jpet.109.150896_bib16","doi-asserted-by":"crossref","unstructured":"Heaton DA, Lei M, Li D, Golding S, Dawson TA, Mohan RM, and Paterson DJ (2006) Remodeling of the cardiac pacemaker L-type calcium current and its beta-adrenergic responsiveness in hypertension after neuronal NO synthase gene transfer. Hypertension 48: 443-452.","DOI":"10.1161\/01.HYP.0000233383.04280.3c"},{"key":"10.1124\/jpet.109.150896_bib17","doi-asserted-by":"crossref","unstructured":"Hirata A, Minamino T, Asanuma H, Fujita M, Wakeno M, Myoishi M, Tsukamoto O, Okada K, Koyama H, Komamura K, et al. (2006) Erythropoietin enhances neovascularization of ischemic myocardium and improves left ventricular dysfunction after myocardial infarction in dogs. J Am Coll Cardiol 48: 176-184.","DOI":"10.1016\/j.jacc.2006.04.008"},{"key":"10.1124\/jpet.109.150896_bib18","doi-asserted-by":"crossref","unstructured":"Hirata A, Minamino T, Asanuma H, Sanada S, Fujita M, Tsukamoto O, Wakeno M, Myoishi M, Okada K, Koyama H, et al. (2005) Erythropoietin just before reperfusion reduces both lethal arrhythmias and infarct size via the phosphatidylinositol-3 kinase-dependent pathway in canine hearts. Cardiovasc Drugs Ther 19: 33-40.","DOI":"10.1007\/s10557-005-6895-1"},{"key":"10.1124\/jpet.109.150896_bib19","doi-asserted-by":"crossref","unstructured":"Jones DL, Petrie JP, and Li HG (2001) Spontaneous, electrically, and cesium chloride induced arrhythmia and afterdepolarizations in the rapidly paced dog heart. Pacing Clin Electrophysiol 24: 474-485.","DOI":"10.1046\/j.1460-9592.2001.00474.x"},{"key":"10.1124\/jpet.109.150896_bib20","doi-asserted-by":"crossref","unstructured":"Jones SP, Girod WG, Huang PL, and Lefer DJ (2000) Myocardial reperfusion injury in neuronal nitric oxide synthase deficient mice. Coron Artery Dis 11: 593-597.","DOI":"10.1097\/00019501-200012000-00004"},{"key":"10.1124\/jpet.109.150896_bib21","doi-asserted-by":"crossref","unstructured":"Joyeux-Faure M, Godin-Ribuot D, and Ribuot C (2005) Erythropoietin and myocardial protection: what\u2019s new? Fundam Clin Pharmacol 19: 439-446.","DOI":"10.1111\/j.1472-8206.2005.00347.x"},{"key":"10.1124\/jpet.109.150896_bib22","doi-asserted-by":"crossref","unstructured":"Katavetin P, Inagi R, Miyata T, Shao J, Sassa R, Adler S, Eto N, Kato H, Fujita T, and Nangaku M (2007) Erythropoietin induces heme oxygenase-1 expression and attenuates oxidative stress. Biochem Biophys Res Commun 359: 928-934.","DOI":"10.1016\/j.bbrc.2007.05.207"},{"key":"10.1124\/jpet.109.150896_bib23","doi-asserted-by":"crossref","unstructured":"Kim KH, Oudit GY, and Backx PH (2008) Erythropoietin protects against doxorubicin-induced cardiomyopathy via a phosphatidylinositol 3-kinase-dependent pathway. J Pharmacol Exp Ther 324: 160-169.","DOI":"10.1124\/jpet.107.125773"},{"key":"10.1124\/jpet.109.150896_bib24","doi-asserted-by":"crossref","unstructured":"Krishnagopalan S, Kumar A, Parrillo JE, and Kumar A (2002) Myocardial dysfunction in the patient with sepsis. Curr Opin Crit Care 8: 376-388.","DOI":"10.1097\/00075198-200210000-00003"},{"key":"10.1124\/jpet.109.150896_bib25","doi-asserted-by":"crossref","unstructured":"Lee ST, Chu K, Sinn DI, Jung KH, Kim EH, Kim SJ, Kim JM, Ko SY, Kim M, and Roh JK (2006) Erythropoietin reduces perihematomal inflammation and cell death with eNOS and STAT3 activations in experimental intracerebral hemorrhage. J Neurochem 96: 1728-1739.","DOI":"10.1111\/j.1471-4159.2006.03697.x"},{"key":"10.1124\/jpet.109.150896_bib26","doi-asserted-by":"crossref","unstructured":"Li Y, Takemura G, Okada H, Miyata S, Maruyama R, Li L, Higuchi M, Minatoguchi S, Fujiwara T, and Fujiwara H (2006) Reduction of inflammatory cytokine expression and oxidative damage by erythropoietin in chronic heart failure. Cardiovasc Res 71: 684-694.","DOI":"10.1016\/j.cardiores.2006.06.003"},{"key":"10.1124\/jpet.109.150896_bib27","unstructured":"Liu X, Shen J, Jin Y, Duan M, and Xu J (2006) Recombinant human erythropoietin (rhEPO) preconditioning on nuclear factor-kappa B (NF-kB) activation & proinflammatory cytokines induced by myocardial ischaemia-reperfusion. Indian J Med Res 124: 343-354."},{"key":"10.1124\/jpet.109.150896_bib28","doi-asserted-by":"crossref","unstructured":"Mancini DM, Katz SD, Lang CC, LaManca J, Hudaihed A, and Androne AS (2003) Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure. Circulation 107: 294-299.","DOI":"10.1161\/01.CIR.0000044914.42696.6A"},{"key":"10.1124\/jpet.109.150896_bib29","doi-asserted-by":"crossref","unstructured":"Marban E, Robinson SW, and Wier WG (1986) Mechanisms of arrhythmogenic delayed and early afterdepolarizations in ferret ventricular muscle. J Clin Invest 78: 1185-1192.","DOI":"10.1172\/JCI112701"},{"key":"10.1124\/jpet.109.150896_bib30","doi-asserted-by":"crossref","unstructured":"Nakata S, Tsutsui M, Shimokawa H, Yamashita T, Tanimoto A, Tasaki H, Ozumi K, Sabanai K, Morishita T, Suda O, et al. (2007) Statin treatment upregulates vascular neuronal nitric oxide synthase through Akt\/NF-kappaB pathway. Arterioscler Thromb Vasc Biol 27: 92-98.","DOI":"10.1161\/01.ATV.0000251615.61858.33"},{"key":"10.1124\/jpet.109.150896_bib31","doi-asserted-by":"crossref","unstructured":"Namiuchi S, Kagaya Y, Ohta J, Shiba N, Sugi M, Oikawa M, Kunii H, Yamao H, Komatsu N, Yui M, et al. (2005) High serum erythropoietin level is associated with smaller infarct size in patients with acute myocardial infarction who undergo successful primary percutaneous coronary intervention. J Am Coll Cardiol 45: 1406-1412.","DOI":"10.1016\/j.jacc.2005.01.043"},{"key":"10.1124\/jpet.109.150896_bib32","doi-asserted-by":"crossref","unstructured":"Nishiya D, Omura T, Shimada K, Matsumoto R, Kusuyama T, Enomoto S, Iwao H, Takeuchi K, Yoshikawa J, and Yoshiyama M (2006) Effects of erythropoietin on cardiac remodeling after myocardial infarction. J Pharmacol Sci 101: 31-39.","DOI":"10.1254\/jphs.FP0050966"},{"key":"10.1124\/jpet.109.150896_bib33","doi-asserted-by":"crossref","unstructured":"Olea FD, Vera Janavel G, De Lorenzi A, Cuniberti L, Yannarelli G, Cabeza Meckert P, Cearras M, Laguens R, and Crottogini A (2006) High-dose erythropoietin has no long-term protective effects in sheep with reperfused myocardial infarction. J Cardiovasc Pharmacol 47: 736-741.","DOI":"10.1097\/01.fjc.0000211766.59636.0d"},{"key":"10.1124\/jpet.109.150896_bib34","doi-asserted-by":"crossref","unstructured":"Pabla R and Curtis MJ (1995) Effects of NO modulation on cardiac arrhythmias in the rat isolated heart. Circ Res 77: 984-992.","DOI":"10.1161\/01.RES.77.5.984"},{"key":"10.1124\/jpet.109.150896_bib35","doi-asserted-by":"crossref","unstructured":"Pabla R and Curtis MJ (1996) Endogenous protection against reperfusion-induced ventricular fibrillation: role of neuronal versus non-neuronal sources of nitric oxide and species dependence in the rat versus rabbit isolated heart. J Mol Cell Cardiol 28: 2097-2110.","DOI":"10.1006\/jmcc.1996.0202"},{"key":"10.1124\/jpet.109.150896_bib36","doi-asserted-by":"crossref","unstructured":"Parsa CJ, Kim J, Riel RU, Pascal LS, Thompson RB, Petrofski JA, Matsumoto A, Stamler JS, and Koch WJ (2004) Cardioprotective effects of erythropoietin in the reperfused ischemic heart: a potential role for cardiac fibroblasts. J Biol Chem 279: 20655-20662.","DOI":"10.1074\/jbc.M314099200"},{"key":"10.1124\/jpet.109.150896_bib37","doi-asserted-by":"crossref","unstructured":"Rui T, Feng Q, Lei M, Peng T, Zhang J, Xu M, Abel ED, Xenocostas A, and Kvietys PR (2005) Erythropoietin prevents the acute myocardial inflammatory response induced by ischemia\/reperfusion via induction of AP-1. Cardiovasc Res 65: 719-727.","DOI":"10.1016\/j.cardiores.2004.11.019"},{"key":"10.1124\/jpet.109.150896_bib38","doi-asserted-by":"crossref","unstructured":"Sears CE, Bryant SM, Ashley EA, Lygate CA, Rakovic S, Wallis HL, Neubauer S, Terrar DA, and Casadei B (2003) Cardiac neuronal nitric oxide synthase isoform regulates myocardial contraction and calcium handling. Circ Res 92: e52-59.","DOI":"10.1161\/01.RES.0000064585.95749.6D"},{"key":"10.1124\/jpet.109.150896_bib39","doi-asserted-by":"crossref","unstructured":"Song W, Lu X, and Feng Q (2000) Tumor necrosis factor-alpha induces apoptosis via inducible nitric oxide synthase in neonatal mouse cardiomyocytes. Cardiovasc Res 45: 595-602.","DOI":"10.1016\/S0008-6363(99)00395-8"},{"key":"10.1124\/jpet.109.150896_bib40","unstructured":"Verheule S, Sato T, and Olgin JE (2006) Cardiac electrophysiology, in A Handbook of Mouse Models of Cardiovascular Disease (Xu Q ed) pp 349-362, John Wiley & Sons, Chichester, UK."},{"key":"10.1124\/jpet.109.150896_bib41","doi-asserted-by":"crossref","unstructured":"Walker MJ, Curtis MJ, Hearse DJ, Campbell RW, Janse MJ, Yellon DM, Cobbe SM, Coker SJ, Harness JB, and Harron DW (1988) The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion. Cardiovasc Res 22: 447-455.","DOI":"10.1093\/cvr\/22.7.447"},{"key":"10.1124\/jpet.109.150896_bib42","doi-asserted-by":"crossref","unstructured":"Xu KY, Huso DL, Dawson TM, Bredt DS, and Becker LC (1999) Nitric oxide synthase in cardiac sarcoplasmic reticulum. Proc Natl Acad Sci U S A 96: 657-662.","DOI":"10.1073\/pnas.96.2.657"},{"key":"10.1124\/jpet.109.150896_bib43","unstructured":"Zaugg CE (2004) Current concepts on ventricular fibrillation: a vicious circle of cardiomyocyte calcium overload in the initiation, maintenance, and termination of ventricular fibrillation. Indian Pacing Electrophysiol J 4: 85-92."}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652438440X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652438440X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.109.150896","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T01:30:04Z","timestamp":1740015004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235652438440X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S002235652438440X"],"URL":"https:\/\/doi.org\/10.1124\/jpet.109.150896","relation":{},"ISSN":["0022-3565"],"issn-type":[{"type":"print","value":"0022-3565"}],"subject":[],"published":{"date-parts":[[2009,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Erythropoietin Protects the Heart from Ventricular Arrhythmia during Ischemia and Reperfusion via Neuronal Nitric-Oxide Synthase","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.109.150896","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2009 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}